Hassan Dihazi

Hassan Dihazi
Professor & Director, Clinical Proteomics Laboratories, Nephrology & Rheumatology, University Medical Center
University of Gottingen, Germany

Biography

Hassan Dihazi is the head of the proteomics group in Department of Nephrology & Rheumatology, in Medical Center at the Georg-August University Goettingen, Germany. He earned his Ph.D. in biochemistry, at biochemistry Institute, Medical Faculty, at University of Leipzig. Currently, he is the head of the clinical proteomics laboratories, and Assoc. Professor in the University Medical Center at the Georg-August University Goettingen. He has published over 40 papers in the field of proteomics. Reviewed papers, and he was author of several book chapters. He has been teaching experience of more than 13 years. He reserved in 2008 The American Association for Clinical Chemistry (AACC) award for "Outstanding Contribution" for the best work published in 2007 in the International Journal “Clinical Chemistry. He served as a reviewer of peer-reviewed journals in the area of cell biology and proteomics. He organized several conferences and as a member and cofounded of the GoProFo, he is involved in the organization of the annual congress of this forum. During last year he established a clinical proteomics research group. He is since 1999 an active member of Association of Biochemistry and Molecular biology (GBM) and since 2003 member of German Proteome Research association (DGPF). He is since 2005 Member of the optimisation committee for Human Kidney and Urine Proteome Project (HKUPP) a HUPO initiative, since 2007 member of the managing committee of the European Kidney and Urine Proteomics (EuroKup). He received many awards like EDTA-ERA award for Jung investigator in 2005 and 2006. He is serving as an editorial member of three journals and is editor in chief of one journal.

Research Interest

Clinical proteomics and biomarker discovery and validation: optimization of urine proteomic protocols for biomarker discovery for diagnostic and therapy for renal diseases. ER-stress pathways in the pathogenesis of renal interstitial fibrosis especially the characterization of the role of ER-calcium binding proteins in establishment of calcium homeostasis and in renal fibrosis progression.